Geron (GERN) News Today $1.92 +0.01 (+0.26%) (As of 10:57 AM ET) Add Compare Share Share Today's Range$1.85▼$1.9250-Day Range$1.74▼$2.1952-Week Range$1.68▼$3.84Volume593,112 shsAverage Volume6.58 million shsMarket Capitalization$1.04 billionP/E RatioN/ADividend YieldN/APrice Target$4.75 HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGeron Corporation Announces Appointment of Gaurav Aggarwal, M.D., to its Board of Directorsfinance.yahoo.com - November 28 at 8:39 AMGeron (GERN) Stock Surges After FDA Removes Full Clinical Hold on Imetelstat Applicationthestreet.com - November 21 at 8:55 PMGeron to Participate at Upcoming Investor Conferences in Novemberfinance.yahoo.com - November 7 at 8:02 PMGeron’s Growth Prospects: Expanding Commercial Team, Imetelstat Development, and Financial Stabilitymarkets.businessinsider.com - November 3 at 10:30 AMGeron Corporation (NASDAQ:GERN) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 3 at 10:30 AMGeron (GERN) Q3 2023 Earnings Call Transcriptfool.com - November 2 at 5:09 PMGeron Corporation 2023 Q3 - Results - Earnings Call Presentationseekingalpha.com - November 2 at 1:07 PMGeron Corporation Q3 Loss beats estimatesmarkets.businessinsider.com - November 2 at 1:01 PMGeron Corporation Reports Business Highlights and Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 2 at 1:01 PMGeron IMerge Phase 3 Presentations at Upcoming ASH Annual Meeting Reinforce Significant Durability and Breadth of Effect of Imetelstat in Lower Risk MDSfinance.yahoo.com - November 2 at 1:01 PMGeron Corp (GERN) Reports Q3 2023 Financial Results and Business Highlightsfinance.yahoo.com - November 2 at 1:01 PM4GERN : Geron Earnings Previewbenzinga.com - November 1 at 3:32 PMTechne (TECH) Q1 Earnings and Revenues Miss Estimatesfinance.yahoo.com - October 31 at 1:02 PMGeron to Announce Third Quarter 2023 Financial Results on November 2, 2023finance.yahoo.com - October 26 at 6:35 PMGeron Corporation Stock: Another Buying Opportunityseekingalpha.com - October 23 at 4:07 PMRhumbline Advisers Has $2.27 Million Stake in Geron Co. (NASDAQ:GERN)marketbeat.com - September 29 at 5:50 PMGeron Reports EMA Validation Of Marketing Authorization Application For Imetelstatmarkets.businessinsider.com - September 29 at 10:14 AMGeron Announces EMA Validation of Marketing Authorization Application for Imetelstat for the Treatment of Lower Risk MDSfinance.yahoo.com - September 29 at 10:14 AMGoldman Sachs Upgrades Geron (GERN)msn.com - September 13 at 12:31 AMGeron Corporation: The FDA, Catalysts And New Competition From Old Drugsmsn.com - September 12 at 6:51 PMFairmount Funds Management LLC Invests $15.42 Million in Geron Co. (NASDAQ:GERN)marketbeat.com - September 12 at 12:39 PMGeron Taps Michelle Robertson to Succeed Olivia Bloom as Finance Chiefmarketwatch.com - September 11 at 9:42 PMGeron Announces Appointment of Michelle Robertson as Executive Vice President, Chief Financial Officer and Treasurer, and the Retirement of Olivia Bloom, Geron's Long-Time ...businesswire.com - September 11 at 9:42 PMGeron announces retirement of CFO Olivia Bloom; appoints Michelle Robertson as new CFOmsn.com - September 11 at 9:42 PMGeron Announces Appointment of Michelle Robertson as Executive Vice President, Chief Financial Officer and Treasurer, and the Retirement of Olivia Bloom, Geron's Long-Time Chief Financial Officerfinance.yahoo.com - September 11 at 9:42 PMGeron Announces Data Presentations from IMerge Phase 3 Evaluating Imetelstat in Lower Risk MDS at Society of Hematologic Oncology Annual Meetingfinance.yahoo.com - September 7 at 4:23 PMGeron to Participate in the Baird 2023 Global Healthcare Conferencefinance.yahoo.com - September 5 at 6:31 PMCitigroup Inc. Grows Stock Holdings in Geron Co. (NASDAQ:GERN)marketbeat.com - September 5 at 4:52 AMPrivate Advisor Group LLC Makes New Investment in Geron Co. (NASDAQ:GERN)marketbeat.com - September 4 at 5:32 AMWedbush adds Geron to Best Ideas List, joining Ascendis, MoonLakemsn.com - September 1 at 5:49 PMShort Interest in Geron Co. (NASDAQ:GERN) Rises By 5.0%marketbeat.com - September 1 at 5:46 PMGeron (GERN) Gets a Buy from Robert W. Bairdmarkets.businessinsider.com - September 1 at 3:09 AMWedbush Keeps Their Buy Rating on Geron (GERN)markets.businessinsider.com - August 30 at 2:38 AMFY2023 EPS Estimates for Geron Co. Increased by Analyst (NASDAQ:GERN)marketbeat.com - August 25 at 6:25 AMFDA's Twist In Geron's Telomerase Tale (Rating Downgrade)seekingalpha.com - August 23 at 1:00 PMMirae Asset Global Investments Co. Ltd. Acquires Shares of 80,666 Geron Co. (NASDAQ:GERN)marketbeat.com - August 23 at 4:24 AMGeron blood cancer therapy accepted for FDA standard reviewseekingalpha.com - August 22 at 3:30 PMGeron: FDA Assigns PDUFA Action Date For NDA For Imetelstatmarkets.businessinsider.com - August 22 at 9:50 AMGeron Announces PDUFA Date for Imetelstat NDA in Lower Risk MDSfinance.yahoo.com - August 22 at 9:50 AMFDA Accepts Geron's NDA For Imetelstat For Treatment Of Lower Risk Myelodysplastic Syndromesmarkets.businessinsider.com - August 21 at 6:49 PMGeron Announces FDA Acceptance of New Drug Application for Imetelstat for the Treatment of Lower Risk MDSfinance.yahoo.com - August 21 at 6:49 PMRobert W. Baird Remains a Buy on Geron (GERN)markets.businessinsider.com - August 8 at 8:36 AMFY2026 EPS Estimates for Geron Co. Cut by Analyst (NASDAQ:GERN)marketbeat.com - August 7 at 8:28 AMGeron Corporation (GERN) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - August 4 at 12:42 PMGoldman Sachs Sticks to Their Hold Rating for Geron (GERN)markets.businessinsider.com - August 4 at 12:42 PMGeron (NASDAQ:GERN) Earns Buy Rating from Needham & Company LLCmarketbeat.com - August 4 at 11:25 AMGeron (GERN) Q2 2023 Earnings Call Transcriptfinance.yahoo.com - August 4 at 2:29 AMGeron: Q2 Earnings Snapshotwashingtonpost.com - August 3 at 8:25 PMGeron Corporation Q2 Loss increases, misses estimatesmarkets.businessinsider.com - August 3 at 8:25 PMGeron Corporation Reports Business Highlights and Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 3 at 8:25 PM Get Geron News Delivered to You Automatically Sign up to receive the latest news and ratings for GERN and its competitors with MarketBeat's FREE daily newsletter. Email Address GERN Media Mentions By Week GERN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GERN News Sentiment▼0.940.82▲Average Medical News Sentiment GERN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GERN Articles This Week▼22▲GERN Articles Average Week Get Geron News Delivered to You Automatically Sign up to receive the latest news and ratings for GERN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LGND News Today MNKD News Today OPK News Today INVA News Today IRWD News Today DVAX News Today LXRX News Today FOLD News Today MDGL News Today ALKS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:GERN) was last updated on 11/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Geron Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.